Thrombopoietin (TPO) is likely to be a potent, specific and reliable medication in the treatment of thrombocytopenia. A TPO-highly-expressed plasmid pcDNA3-TPO was constructed and a primary study was made on the expression of TPO cDNA in vitro and gene transfer study for thrombocytopenia in vivo. rhTPO showed complete and stable bioactivity by a series of indicators. High expression of TPO was detected in plasma from healthy mice or thrombocytopenia mice model receiving direct intramuscular injection of pcDNA3-TPO. And the platelet level of healthy mice peaked to 1.9-fold of baseline. Mice with CTX-induced thrombocytopenia achieved profound nadirs, acceleration of recovery, even 1.8—2.0-fold supranormal levels of peripheral platelet counts. The results offered experimental support for clinical application of gene therapy for thrombocytopenia via direct intramuscular injection of TPO cDNA.
展开▼
机译:Study on Risk Management of Epidemic Prevention in High Rise Residential Areas of Urban Community from the Perspective of COVlD-19: A Case Study of L Community in Handan City
机译:Qualitative and Comparative Study of Different Methods of Interpolation for the Mapping of Groundwater Salinity: Case Study of Thermal Waters Used for Irrigation in Northeastern Algeria
机译:如何发展银行品牌形象-以专注于财富管理业务的远东国际商业银行为例 =The Study of the Development of Bank’s Brand Image- A Case Study of Far Eastern Int’l Bank Targeting on Wealth Management